Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
11,181,416
-
Total 13F shares
-
32,747,670
-
Share change
-
+1,080,490
-
Total reported value
-
$41,911,271
-
Price per share
-
$1.28
-
Number of holders
-
46
-
Value change
-
+$1,300,847
-
Number of buys
-
10
-
Number of sells
-
29
Institutional Holders of Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) as of Q1 2025
As of 31 Mar 2025,
Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,747,670 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, Blue Owl Capital Holdings LP, BVF INC/IL, BML Capital Management, LLC, ORBIMED ADVISORS LLC, Deep Track Capital, LP, Omega Fund Management, LLC, VANGUARD GROUP INC, GILEAD SCIENCES, INC., and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
46
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.